Stay updated on Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial
Sign up to get notified when there's something new on the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page.

Latest updates to the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision label was updated from v3.6.4 to v3.6.5, signaling a minor behind-the-scenes update to the page version.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision banner updated from v3.6.3 to v3.6.4 on the page. This is a minor internal version update with no changes to study content or user-facing information.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a behind-the-scenes update; no visible changes to study content or sections are indicated.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page footer now displays Revision: v3.6.2, reflecting a platform version update for the page.SummaryDifference0.0%

- Check59 days agoChange DetectedEnrollment status on the study page indicates recruitment is closed. New sections for reading the study record, common questions, and joining a study were added to guide users, and a formatting tweak adjusts the Intervention/Treatment header along with a revision label.SummaryDifference0.3%

- Check66 days agoChange DetectedRenamed the study location from Jilin, China, 130021 to Jilin City, China, 130021, and updated the page revision from v3.5.4 to v3.5.5.SummaryDifference0.1%

Stay in the know with updates to Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page.